As of 2025-06-30, the EV/EBITDA ratio of Profound Medical Corp (PRN.TO) is -5.25. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRN.TO's latest enterprise value is 185.36 mil CAD. PRN.TO's TTM EBITDA according to its financial statements is -35.33 mil CAD. Dividing these 2 quantities gives us the above PRN.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 23.7x | 22.6x |
| Forward P/E multiples | 18.0x - 22.8x | 22.5x |
| Fair Price | (27.19) - (34.72) | (34.38) |
| Upside | -437.3% - -530.7% | -526.5% |
| Date | EV/EBITDA |
| 2025-06-27 | -5.68 |
| 2025-06-26 | -5.96 |
| 2025-06-25 | -5.99 |
| 2025-06-24 | -6.04 |
| 2025-06-23 | -5.84 |
| 2025-06-20 | -6.29 |
| 2025-06-19 | -6.65 |
| 2025-06-18 | -6.82 |
| 2025-06-17 | -6.74 |
| 2025-06-16 | -6.65 |
| 2025-06-13 | -6.44 |
| 2025-06-12 | -6.07 |
| 2025-06-11 | -6.79 |
| 2025-06-10 | -6.56 |
| 2025-06-09 | -5.52 |
| 2025-06-06 | -5.31 |
| 2025-06-05 | -5.30 |
| 2025-06-04 | -5.20 |
| 2025-06-03 | -5.30 |
| 2025-06-02 | -5.28 |
| 2025-05-30 | -4.96 |
| 2025-05-29 | -5.03 |
| 2025-05-28 | -5.06 |
| 2025-05-27 | -5.06 |
| 2025-05-26 | -5.19 |
| 2025-05-23 | -4.74 |
| 2025-05-22 | -4.88 |
| 2025-05-21 | -4.93 |
| 2025-05-20 | -4.74 |
| 2025-05-16 | -4.46 |
| 2025-05-15 | -4.15 |
| 2025-05-14 | -3.61 |
| 2025-05-13 | -3.88 |
| 2025-05-12 | -3.93 |
| 2025-05-09 | -4.28 |
| 2025-05-08 | -4.69 |
| 2025-05-07 | -4.43 |
| 2025-05-06 | -4.65 |
| 2025-05-05 | -5.25 |
| 2025-05-02 | -5.07 |
| 2025-05-01 | -4.52 |
| 2025-04-30 | -4.72 |
| 2025-04-29 | -4.57 |
| 2025-04-28 | -4.40 |
| 2025-04-25 | -4.40 |
| 2025-04-24 | -4.41 |
| 2025-04-23 | -4.50 |
| 2025-04-22 | -4.32 |
| 2025-04-21 | -4.28 |
| 2025-04-17 | -4.45 |